Vialwirebiotech, curated
July 22, 2026, 2:02 AM
June 28, 2026
- 12:00 AM · BioWorld12:00 AMFDA says yes to Viridian’s Lumvoa in TED — BioWorld
June 26, 2026
- 12:00 PM · BioWorld12:00 PMHigh-profile Nature retraction tests confidence in China-led studies — BioWorld
- 12:00 PM · BioWorld12:00 PMEMA to pull Amgen’s Tavneos over ‘incorrect and misleading’ data — BioWorld
- 11:49 AM · BioPharma Dive11:49 AMAt BIO, tension over China biotech deal regulation looms — BioPharma Dive
- 9:46 AM · BioPharma Dive9:46 AMAlkermes’ incoming CEO has a plan to outplay Lilly and Takeda — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMElixirgen and Nippon Shinyaku sign EXG-7001 option agreement — BioWorld
- 9:00 AM · BioWorld9:00 AMOblenio’s $62M series B for trispecific antibody in autoimmune diseases — BioWorld
- 8:29 AM · STAT News
- 8:20 AM · FT — Pharmaceuticals8:20 AMBrussels launches antitrust probe into French drugmaker Sanofi — FT — Pharmaceuticals
- 6:23 AM · Pharmaceutical Technology6:23 AMImmunai and Boehringer partner to identify T-cell targets — Pharmaceutical Technology
- 5:27 AM · Pharmaceutical Technology5:27 AMLilly-backed Absci banks $100m to progress endometriosis, hair loss therapy — Pharmaceutical Technology
- 5:17 AM · Pharmaceutical Technology5:17 AMIonis grants Recordati rights to zilganersen for Alexander disease — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMThalia acquires Sanmirna and AML RNA therapy — Drug Discovery World
- 4:00 AM · Drug Discovery World4:00 AMNICE recommends immunotherapy to treat cervical cancer — Drug Discovery World